NYSE:CBM Cambrex (CBM) Stock Price, News & Analysis → Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It! (From American Alternative) (Ad) Free CBM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$59.99▼$59.9950-Day Range$59.99▼$59.9952-Week Range$33.80▼$60.29VolumeN/AAverage Volume218,726 shsMarket Capitalization$2.02 billionP/E Ratio21.66Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cambrex alerts: Email Address Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW About Cambrex Stock (NYSE:CBM)Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as finished dosage forms. The company serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.Read More Ad American AlternativeUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...CLICK HERE TO GET YOUR GUIDE NOW CBM Stock News HeadlinesMarch 27, 2024 | tmcnet.comOne Equity Partners Invests in Italian Agricultural Tractor Attachment Manufacturer CBMMarch 19, 2024 | morningstar.comChina CBM Group Co Ltd 08270April 25, 2024 | American Alternative (Ad)Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...November 2, 2023 | finance.yahoo.comCambrex Announces Sale of Drug Product Business UnitOctober 29, 2023 | investing.comCBM_old Historical DataOctober 24, 2023 | finance.yahoo.comSnapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API DevelopmentOctober 18, 2023 | stockhouse.comSK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023September 21, 2023 | businesswire.comSK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough MedicinesApril 25, 2024 | American Alternative (Ad)Urgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st This guide shows you what to do next. In a cashless society, Biden forces you to use the government's new "digital dollar"...September 7, 2023 | finance.yahoo.comCleantech Building Materials: Result of General MeetingAugust 29, 2023 | markets.businessinsider.comDIVERGENT Energy Services Announces the Release of 2023 Second Quarter ResultsAugust 14, 2023 | finance.yahoo.comCleantech Building Materials: Notice of General MeetingMay 31, 2023 | markets.businessinsider.comCambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial AgreementMay 30, 2023 | juniorminingnetwork.comCollective Mining Drills 162.20 Metres at 3.90 g/t Gold Equivalent From Surface at the...January 18, 2023 | prnewswire.comCambrex fait l'acquisition de Snapdragon Chemistry, un leader dans les services de développement d'IPA à flux continuDecember 24, 2022 | msn.comRepair works at LRT, MRT, Monorail stations to be completed by FebruaryOctober 14, 2022 | businesswire.comVitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028 - ResearchAndMarkets.com - Business WireOctober 9, 2022 | benzinga.comWith 5.0% CAGR, Small Molecule API Market Size Worth US$ 300.2 Billion by 2030 | Research for Developing - BenzingaOctober 5, 2022 | markets.businessinsider.comCambrex Announces Stability Storage Expansions in Ireland and BelgiumOctober 4, 2022 | prnewswire.comCambrex Announces Stability Storage Expansions in Ireland and Belgium - PR NewswireSeptember 28, 2022 | streetinsider.comMedicx Health Appoints Theresa Greco as President and Stacey Levas as Senior Vice President of Marketing - StreetInsider.comSeptember 27, 2022 | prnewswire.comInvestigational New Drug CDMO Market worth $7.47 billion by 2030 - Exclusive Report by InsightAce Analytic - PR NewswireSeptember 20, 2022 | finance.yahoo.comBlockchain Moon Acquisition Corp. appoints John P. Hopkins and Carl J. Johnson as new Independent Directors - Yahoo FinanceSeptember 19, 2022 | msn.comONGC wants government to scrap windfall tax on domestically produced crude oilSeptember 19, 2022 | msn.comONGC wants govt to scrap windfall tax, USD 10 gas priceSeptember 16, 2022 | businesswire.comKimball Electronics, Inc. Announces Appointment of Additional Director - Business WireSeptember 2, 2022 | news.yahoo.comCambrex finishes first phase of expansion - Yahoo NewsSee More Headlines Receive CBM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cambrex and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/02/2018Today4/24/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Pharmaceutical Preparations Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:CBM CUSIP13201110 CIK820081 Webwww.cambrex.com Phone201-804-3000FaxN/AEmployees1,732Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$2.77 Trailing P/E Ratio21.66 Forward P/E RatioN/A P/E GrowthN/ANet Income$92.41 million Net Margins5.96% Pretax MarginN/A Return on Equity5.38% Return on Assets2.50% Debt Debt-to-Equity Ratio0.76 Current Ratio2.37 Quick Ratio1.70 Sales & Book Value Annual Sales$532.09 million Price / Sales3.80 Cash Flow$3.91 per share Price / Cash Flow15.36 Book Value$19.48 per share Price / Book3.08Miscellaneous Outstanding Shares33,720,000Free FloatN/AMarket Cap$2.02 billion OptionableOptionable Beta2.14 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Steven M. Klosk (Age 62)Pres, CEO & Director Mr. Gregory P. Sargen (Age 53)Exec. VP of Corp. Devel. & Strategy and CFO Mr. Shawn P. Cavanagh (Age 53)Exec. VP & COO Ms. Samantha M. Hanley (Age 41)VP, Gen. Counsel & Corp. Sec. Mr. James G. Farrell (Age 52)VP & Corp. Controller Key CompetitorsAvidity BiosciencesNASDAQ:RNAAmphastar PharmaceuticalsNASDAQ:AMPHKeros TherapeuticsNASDAQ:KROSPTC TherapeuticsNASDAQ:PTCTMaravai LifeSciencesNASDAQ:MRVIView All Competitors CBM Stock Analysis - Frequently Asked Questions How were Cambrex's earnings last quarter? Cambrex Co. (NYSE:CBM) posted its earnings results on Thursday, August, 2nd. The biotechnology company reported $0.74 EPS for the quarter, topping analysts' consensus estimates of $0.69 by $0.05. The biotechnology company earned $152.05 million during the quarter, compared to analysts' expectations of $132.78 million. Cambrex had a net margin of 5.96% and a trailing twelve-month return on equity of 5.38%. The business's revenue for the quarter was up 13.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.76 earnings per share. What other stocks do shareholders of Cambrex own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cambrex investors own include Illumina (ILMN), AbbVie (ABBV), NVIDIA (NVDA), CVS Health (CVS), Gilead Sciences (GILD), Intel (INTC), Walt Disney (DIS), Juno Therapeutics (JUNO) and Under Armour (UAA). This page (NYSE:CBM) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry Research1970’s computer coder issues shocking A.I. warningTradeSmithExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambrex Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
